Contact allergy to corticosteroids: Is the European baseline series sufficient?
Contact Dermatitis · 2023
DOI: 10.1111/cod.14358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2023. Verfasst von Sebastian Vigand Svendsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense C, Denmark. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Patients are consecutively screened for contact allergy to corticosteroids with budesonide and tixocortol‐21‐pivalate in the European baseline series. Centres using TRUE Test also include hydrocortisone‐17‐butyrate. A supplementary corticosteroid patch test series is used in case of suspicion of corticosteroid contact allergy or when a marker of corticosteroid contact allergy is positive.
Objective
The aims were to evaluate (1) the efficacy of corticosteroids in the TRUE Test and (2) co‐sensitization patterns.
Methods
This retrospective study analysed patients patch tested with TRUE Test corticosteroids plus supplementary corticosteroid series in the period 2006–2020 at the Department of Dermatology and Allergy Centre, Odense University Hospital.
Results
Of 1852 patients tested, 119 were sensitised to TRUE Test corticosteroids and supplementary testing found additional reactions to other corticosteroids in 19 of 119 patients. TRUE Test corticosteroids gave more positive and stronger reactions compared to allergens in petrolatum/ethanol. Fourteen percent of sensitised patients were co‐sensitised to multiple corticosteroid groups. Baeck group 3 corticosteroids accounted for 9 of 16 patients not identified by TRUE Test.
Conclusions
Budesonide, hydrocortisone‐17‐butyrate, and tixocortol‐21‐pivalate in combination are sensitive corticosteroid markers. In case of clinical suspicion of corticosteroid contact allergy, patch testing with supplementary corticosteroids is highly recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense C, Denmark.
ORCID-Profile: Sebastian Vigand Svendsen, Carsten Bindslev-Jensen, Charlotte G Mortz
Zitieren
APA
Svendsen, S. V., Bindslev-Jensen, C., & Mortz, C. G. (2023). Contact allergy to corticosteroids: Is the European baseline series sufficient?. Contact Dermatitis. https://doi.org/10.1111/cod.14358
Vancouver
Svendsen SV, Bindslev-Jensen C, Mortz CG. Contact allergy to corticosteroids: Is the European baseline series sufficient?. Contact Dermatitis. 2023. doi:10.1111/cod.14358
BibTeX
@article{Svendsen2023,
author = {Svendsen, Sebastian Vigand and Bindslev-Jensen, Carsten and Mortz, Charlotte G},
title = {Contact allergy to corticosteroids: Is the European baseline series sufficient?},
journal = {Contact Dermatitis},
year = {2023},
doi = {10.1111/cod.14358}
}
EUVIMED